James Mario Termini
- University of Miami School of Medicine · Pathology (NIH department code)
From the FY2026 NIH awards this investigator leads as contact PI. The department is the award's.
FY2026 NIH rank #34,499
- R01 Holder
- Early Career
Researcher identity and coverage
- Current affiliation
- Not verified in ScienceDex.NIH award organizations may differ from a researcher's employer.
- NIH RePORTER identity
- Profile ID 12533493Search this ID in NIH RePORTER
- ORCID iD
- No ORCID iD on recordA researcher can add one by claiming this profile.
- ScienceDex PI coverage
- FY2026 onlyCareer claims are limited to the years shown.
FY2026 award categories
- Pathology
NIH Funding · FY2026
Linked Award Amount
$457.1K
Full award amounts, FY2026
Award Records
1
Records listing this PI
Award-Linked Rank
#34,499
By linked amount among FY2026 PIs
Earliest Year Loaded
2026
ScienceDex PI coverage
Award data coverage
ScienceDex currently has one fiscal year of PI ranking data for this record. This does not establish the first NIH award or current employer.
Single fiscal year on record (FY2026): $457.1K in linked award amounts across 1 award record · Award-linked rank #34499.
FY2026 award records by amount
NIH award records listing James Mario Termini as a PI. Multi-PI records show the full award amount for context.
- 1R01AI203544-01R01Contact PIEngineered Probiotics as a Strategy to Induce Oral Tolerance to AAV-Delivered Broadly Neutralizing AntibodiesUniversity of Miami School of Medicine · Pathology (NIH department code)$457.1Kaward amount
Award organization
Organizations that administered FY2026 awards listing James Mario Termini as a PI.
FY2026 award administered by University of Miami School of Medicine (FL).
Coverage and award-record milestones
Computed from the fiscal years currently available in ScienceDex.
- 2026First NIH AwardUniversity of Miami School of Medicine